C12Y 207/0802
Phosphatidylglycerol--membrane-oligosaccharide glycerophosphotransferase
Official title: Phosphatidylglycerol--membrane-oligosaccharide glycerophosphotransferase (2.7.8.20)
C12Y207/0802 (Phosphatidylglycerol--membrane-oligosaccharide glycerophosphotransferase) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 3
- Assignees
- 3
- Inventors
- 5
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered strains with reduced byproduct formation17 Feb 2026US 12,553,071 B2Dsm IP Assets B.V.
- Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses29 May 2018US 9,980,992 B2North Carolina State University
- Recombinant Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses17 May 2016US 9,340,792 B2North Carolina State University
- Genetically engineered strains with reduced byproduct formation12 Dec 2024US 2024/0409972 A1Dsm IP Assets B.V.
- Recombinant lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses10 Nov 2016US 2016/0324905 A1North Carolina State University
- Recombinant lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses29 Aug 2013US 2013/0224153 A1North Carolina State University
Most cited
By later US patents